Q2 2016 Holdings
Filed 2016-08-15 | 84 holdings | $79.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $16.6M | 901,286 | 20.9% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $13.2M | 498,117 | 16.6% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $13.1M | 1,499,226 | 16.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $11.1M | 200,355 | 13.9% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $9.7M | 576,106 | 12.2% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $5.4M | 455,515 | 6.8% |
| Cytomx Therapeutics(CTMX) | COM | 23284F105 | $3.8M | 371,636 | 4.8% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $3.1M | 214,132 | 3.8% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $2.1M | 50,000 | 2.6% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $826.0K | 62,254 | 1.0% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $206.0K | 25,307 | 0.3% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $42.2K | 1,689,071 | 0.1% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $36.2K | 491,044 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $32.0K | 1,771,263 | 0.0% |
| Tesaro Inc | COM | 881569107 | $30.5K | 362,875 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $28.8K | 2,022,879 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $28.6K | 2,800,000 | 0.0% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $25.4K | 1,118,372 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $22.0K | 730,000 | 0.0% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $19.6K | 505,995 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $19.1K | 707,978 | 0.0% |
| Vitae Pharmaceuticals Inc | COM | 92847N103 | $18.9K | 1,754,795 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $18.3K | 334,044 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $18.1K | 398,301 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $18.0K | 1,710,000 | 0.0% |
| Proteostasis Therapeutics in | COM | 74373B109 | $16.4K | 1,354,339 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $13.9K | 1,988,208 | 0.0% |
| China Biologic Prods Inc | COM | 16938C106 | $12.0K | 112,867 | 0.0% |
| Quotient LTD | SHS | G73268107 | $11.9K | 1,537,717 | 0.0% |
| Sorrento Therapeutics Inc(SRNE) | COM NEW | 83587F202 | $11.9K | 2,121,013 | 0.0% |
| Novavax Inc | COM | 670002104 | $11.8K | 1,619,608 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $9.4K | 758,290 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $9.3K | 396,000 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $9.3K | 635,000 | 0.0% |
| Relypsa Inc | COM | 759531106 | $8.3K | 450,000 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $8.2K | 394,407 | 0.0% |
| Sangamo Biosciences Inc(SGMO) | COM | 800677106 | $8.1K | 1,402,331 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $7.9K | 100,000 | 0.0% |
| Achillion Pharmaceuticals in(ACHNEUR) | COM | 00448Q201 | $7.8K | 1,006,128 | 0.0% |
| Inc Resh Hlds Inc CL A | CL A | 45329R109 | $7.6K | 200,000 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $7.4K | 253,064 | 0.0% |
| Advaxis Inc | COM NEW | 007624208 | $6.6K | 809,804 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $6.4K | 1,578,106 | 0.0% |
| Recro Pharma Inc | COM | 75629F109 | $6.2K | 778,288 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $6.2K | 339,175 | 0.0% |
| Corbus Pharmaceuticals Hldgs(CRBPEUR) | COM | 21833P103 | $6.0K | 2,000,000 | 0.0% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $5.4K | 110,842 | 0.0% |
| Pfenex Inc | COM | 717071104 | $5.3K | 632,559 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $5.0K | 172,083 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $4.3K | 127,451 | 0.0% |